Pandemic-struck EU member states are worried about debt and are hesitant to reach for recovery fund loans, and a Covid-19 vaccine trial out of the University of Oxford and AstraZeneca has shown promise in a recent trial. Plus, the FT’s Peter Foster and Judith Evans explain what kind of complications will occur at the UK border after the Brexit transition period ends.
Italy and Spain introduce new pandemic measures
EU capitals hesitate over recover fund loans
Astrazeneca Oxford Covid vaccine trials offer hope for the elderly
British sausage makers face EU freeze after Brexit
Private jets take off as wealthy flyers seek to avoid virus
See acast.com/privacy for privacy and opt-out information.
A transcript for this podcast is currently unavailable, view our accessibility guide.